Our new Cryptocurrency section has arrived! Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVerseon Corporation Regulatory News (VSN)

  • There is currently no data for VSN

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.
12
Date   Source Headline
15th Mar 201912:00 pmRNSVerseon Corporation - Change of TIDM
4th Mar 20197:00 amRNSVerseon Corporation - Additional Listing & Total Voting Rights
11th Feb 20197:00 amRNSVerseon Corporation - Verseon presents low bleed PROACs at ISC 2019
4th Feb 20197:00 amRNSVerseon Corporation - First participant dosed in Verseon clinical trial
29th Jan 20197:00 amRNSVerseon Corporation - Directorate Change
8th Jan 201912:00 pmRNSVerseon Corporation - Additional listing confirmation
3rd Jan 201910:20 amRNSVerseon Corporation - Additional Listing & Total Voting Rights
6th Nov 20187:00 amRNSVerseon Corporation - Result of AGM and changes to the Board
5th Nov 20187:00 amRNSVerseon Corporation - Additional Listing & Total Voting Rights
24th Oct 20187:00 amRNSVerseon Corporation - Announcement of 2018 Annual General Meeting
1st Oct 20188:59 amRNSVerseon Corporation - Additional Listing & Total Voting Rights
18th Sep 20187:00 amRNSVerseon Corporation - Verseon unveils new blockchain technology
13th Sep 20187:00 amRNSVerseon Corporation - Verseon commences anticoagulant phase I trial
2nd Jul 20187:00 amRNSVerseon Corporation - Additional Listing & Total Voting Rights
13th Jun 20187:03 amRNSVerseon Corporation - Verseon closes US$ 22.7M mortgage
12th Jun 20187:00 amRNSVerseon Corporation - Additional Listing & Total Voting Rights
18th Apr 20187:00 amRNSVerseon Corporation - Verseon presents anticancer agents at AACR 2018
10th Jan 20187:00 amRNSVerseon presents HAE program at Biotech Showcase
14th Nov 20177:00 amRNSAdditional Listing & Total Voting Rights
8th Nov 20177:00 amRNSVerseon presents anticancer agents at BIO-Europe
25th Sep 20177:00 amRNSInterim Results
22nd Sep 20177:00 amRNSVerseon closes PACE financing for its new facility
7th Aug 20177:00 amRNSAdditional Listing and Total Voting Rights
26th Jun 20177:00 amRNSVerseon presents data on DME program at BIO 2017
12th Jun 20177:00 amRNSVerseon to present drug programs at BIO 2017
3rd Apr 20177:00 amRNSAnnouncement of 2017 Annual General Meeting
30th Mar 20177:00 amRNSVerseon to present anticoagulants at ACS 2017
20th Mar 20177:00 amRNSBIO-Europe Spring: Verseon presents anticoagulants
13th Mar 20177:00 amRNSFinal Results
6th Dec 20167:00 amRNSLower bleeding risk of Verseon anticoagulants
16th Nov 20167:00 amRNSAdditional Listing & Total Voting Rights
14th Nov 20167:00 amRNSNew anticoagulant data to be presented at AHA 2016
7th Nov 20167:00 amRNSAppointment of Corporate Brokers
12th Sep 20167:00 amRNSAdditional Listing & Total Voting Rights
5th Sep 20167:00 amRNSInterim Results
7th Apr 20167:00 amRNSNotice of AGM
4th Apr 20167:00 amRNSVerseon to present additional results at BioEurope
22nd Mar 201612:30 pmRNSVeresen Concludes Key Terms with JERA for Jordan Cove Liquefaction Capacity
21st Mar 20167:00 amRNSHoldings in Company
17th Mar 20167:00 amRNSAdditional Listing & Total Voting Rights
7th Mar 20167:00 amRNSFinal Results
1st Mar 20167:00 amRNSAdditional Listing & Total Voting Rights
10th Feb 20167:00 amRNSVerseon to present new preclinical results at ICHB
4th Feb 20167:00 amRNSAdditional Listing & Total Voting Rights
12th Jan 20167:00 amRNSVerseon to Present Data
29th Oct 20157:00 amRNSAdditional Listing & Total Voting Rights
28th Aug 20159:34 amRNSDepository Interest Programme
20th Aug 20158:55 amRNSVerseon Acquires R&D Facility
25th Jun 20159:57 amRNSHolding(s) in Company
23rd Mar 20152:02 pmRNSVeresen Announces $200 Million Preferred Share Offering
12

Login to your account

Don't have an account? Click here to register.